» Articles » PMID: 22362384

Nitric Oxide Release: Part II. Therapeutic Applications

Overview
Journal Chem Soc Rev
Specialty Chemistry
Date 2012 Feb 25
PMID 22362384
Citations 233
Authors
Affiliations
Soon will be listed here.
Abstract

A wide range of nitric oxide (NO)-releasing materials has emerged as potential therapeutics that exploit NO's vast biological roles. Macromolecular NO-releasing scaffolds are particularly promising due to their ability to store and deliver larger NO payloads in a more controlled and effective manner compared to low molecular weight NO donors. While a variety of scaffolds (e.g., particles, dendrimers, and polymers/films) have been cleverly designed, the ultimate clinical utility of most NO-releasing macromolecules remains unrealized. Although not wholly predictive of clinical success, in vitro and in vivo investigations have enabled a preliminary evaluation of the therapeutic potential of such materials. In this tutorial review, we review the application of macromolecular NO therapies for cardiovascular disease, cancer, bacterial infections, and wound healing.

Citing Articles

A macrophage-like biomimetic nanoparticle with high-efficiency biofilm disruption and innate immunity activation for implant-related infection therapy.

Wei G, Xiao T, Xi Y, Ju R Mater Today Bio. 2025; 31:101575.

PMID: 40051528 PMC: 11883385. DOI: 10.1016/j.mtbio.2025.101575.


Red light excitation: illuminating photocatalysis in a new spectrum.

Fortier L, Lefebvre C, Hoffmann N Beilstein J Org Chem. 2025; 21:296-326.

PMID: 39931681 PMC: 11809576. DOI: 10.3762/bjoc.21.22.


Anti-Infective Bacteriophage Immobilized Nitric Oxide-Releasing Surface for Prevention of Thrombosis and Device-Associated Infections.

Gondil V, Ashcraft M, Ghalei S, Kumar A, Wilson S, Devine R ACS Appl Bio Mater. 2025; 8(2):1362-1376.

PMID: 39895136 PMC: 11836933. DOI: 10.1021/acsabm.4c01638.


Emerging strategies for nitric oxide production and their topical application as nanodressings to promote diabetic wound healing.

Xia D, Guo Y, Xu R, Li N J Nanobiotechnology. 2025; 23(1):53.

PMID: 39881346 PMC: 11776289. DOI: 10.1186/s12951-025-03135-1.


Harnessing the Power of Our Immune System: The Antimicrobial and Antibiofilm Properties of Nitric Oxide.

Roberts J, Milo S, Metcalf D Microorganisms. 2025; 12(12.

PMID: 39770746 PMC: 11677572. DOI: 10.3390/microorganisms12122543.


References
1.
Ni S, Stephenson S, Lee R . Folate receptor targeted delivery of liposomal daunorubicin into tumor cells. Anticancer Res. 2002; 22(4):2131-5. View

2.
Al-Sadoni H, Ferro A . Current status and future possibilities of nitric oxide-donor drugs: focus on S-nitrosothiols. Mini Rev Med Chem. 2005; 5(3):247-54. DOI: 10.2174/1389557053175399. View

3.
Veerapandian M, Yun K . Functionalization of biomolecules on nanoparticles: specialized for antibacterial applications. Appl Microbiol Biotechnol. 2011; 90(5):1655-67. DOI: 10.1007/s00253-011-3291-6. View

4.
Wallace J . Building a better aspirin: gaseous solutions to a century-old problem. Br J Pharmacol. 2007; 152(4):421-8. PMC: 2050827. DOI: 10.1038/sj.bjp.0707396. View

5.
Frost M, Rudich S, Zhang H, Maraschio M, Meyerhoff M . In vivo biocompatibility and analytical performance of intravascular amperometric oxygen sensors prepared with improved nitric oxide-releasing silicone rubber coating. Anal Chem. 2002; 74(23):5942-7. DOI: 10.1021/ac025944g. View